Medicina · 2024 · 10 citations · 34 references
MedicineCardiologyInternal MedicineClinical CardiologyClinical EpidemiologyEarly DetectionAtrial FibrillationCardiac BiomarkersCardiac Risk AssessmentCardiovascular DiseaseStrokeThrombosisComprehensive Tee ExaminationEchocardiographic BiomarkersInflammation QuantificationIschemic Stroke PrognosticationLogistic RegressionLogistic Regression AnalysisPrognostic VariablesSystemic Inflammation Markers
Background and Objectives: Studies have shown that inflammation markers can be used as prognostic tools in predicting acute ischemic stroke. In this study, we conducted a comparison of several inflammation scores in predicting left atrial thrombosis (LAT) in patients with ischemic stroke without AF. Materials and Methods: In this single-center, retrospective study, we included 303 consecutive patients with ischemic stroke. Each patient underwent a transesophageal echocardiography (TEE) examination within 10 days of admission to detect the presence of LAT. To identify independent predictors of LAT, we conducted a multivariate logistic regression analysis. Results: In total, 303 patients who had ischemic stroke were included in the analysis. LAT was detached in 34 patients at the time of the TEE examination. The patients were categorized into two groups based on their LAT status. The Prognostic Nutritional Index (PNI), HALP score, and C-reactive Protein–Albumin Ratio (CAR) were identified as statistically significant predictors of LAT. Based on the results of the multivariate regression analysis, the CAR emerged as the only independent predictor of LAT. Conclusions: Among several inflammation scores, the PNI, HALP, and CAR were statistically significant predictors of LAT in ischemic stroke patients without AF. CAR was identified as the optimal score for the prediction of LAT in patients with stroke and without AF.
34
World Stroke Organization (WSO): Global Stroke Fact Sheet 2022
Valery L. Feigin, Michael Brainin, Bo Norrving et al. · International Journal of Stroke · 2022 · 2.8K citations
B-type natriuretic peptide in cardiovascular disease
James A. de Lemos, Darren K. McGuire, Mark H. Drazner · The Lancet · 2003 · 1.1K citations